Why IMU is a multi multi bagger, page-25981

Azer-cell Phase 1b allogeneic (allo) CAR T study ongoingmulti-centre Phase 1b clinical trial for DLBCL patients who relapsed following CAR T treatment

Imugene Shareholder Enquiries - question.

Can you please confirm whether or not Imugene is treating DLBCL patientsfor the above trial at St Vincent’s Hospital Melbourne.

I thought the completion of the Azer-cell Phase 1b clinical trial wasonly at US centres.

Reply :-

Thank you for your email.

Unfortunately, under the selective disclosureobligations of the ASX we are unable to respond to enquiries in a private emailabout matters which are not in the public domain.

As per the Appendix 4C released in April 2024,the azer-cel trial is being conducted in 15 sites in the US, with plans to openup to five sites in Australia.

Kind regards

Mike Tonroe

Chief Financial Officer